About Us

Visit Diapharma to discuss Keratin 18 (CK18/K18) assays as prescreening tools and secondary endpoints in NASH clinical trials. Learn about our panels of mechanistic biomarkers that provide insight into the biological processes occurring during liver injury. Explore M30/M65 ELISAs for measuring hepatocyte apoptosis/necrosis non‐invasively. Diapharma offers an extensive line of exploratory biomarkers for liver injury, including sCD163, L-FABP, α‐GST, and Collagen IV. Research use only.

Team Members

Mike Hambleton Picture

Michael Hambleton, Ph.D.

Executive Vice President

Jessica Tuohy Picture

Jessica Tuohy, Ph.D.

Scientific Product Manager


Olivia Stricker, Ph.D.

Commerical Business Development Manager